Cargando…
YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma
BACKGROUND: The polycomb transcription factor Yin Yang 1 (YY1) overexpression can be causally implicated in experimental tumor growth and metastasization. To date, there is no clinical evidence of YY1 involvement in outcome of patients with osteosarcoma. Prognosis of osteosarcoma is still severe and...
Autores principales: | Nigris, Filomena de, Zanella, Licciana, Cacciatore, Francesco, Chiara, Anna De, Fazioli, Flavio, Chiappetta, Gennaro, Apice, Gaetano, Infante, Teresa, Monaco, Mario, Rossiello, Raffaele, Rosa, Gaetano De, Alberghini, Marco, Napoli, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240836/ https://www.ncbi.nlm.nih.gov/pubmed/22047406 http://dx.doi.org/10.1186/1471-2407-11-472 |
Ejemplares similares
-
Ex Vivo Behaviour of Human Bone Tumor Endothelial Cells
por: Infante, Teresa, et al.
Publicado: (2013) -
Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
por: Colella, Gianluca, et al.
Publicado: (2018) -
Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
por: Scognamiglio, Giosue, et al.
Publicado: (2019) -
Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response
por: Mosca, Laura, et al.
Publicado: (2022) -
Post-surgery fluids promote transition of cancer stem cell-to-endothelial and AKT/mTOR activity, contributing to relapse of giant cell tumors of bone
por: Fazioli, Flavio, et al.
Publicado: (2017)